Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic Nephropathy
NCT07786168Completed
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised trial of roxadustat in anemia (2 arms). Primary endpoint: Change in Hemoglobin Level From Baseline at 3 months. Started Dec 2025; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07786168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07786168.